Browse the full management transaction log of WuXi Biologics (Cayman) Inc., a listed equity based in Hong Kong. Shares are listed on HK HK, under the authority of HKEX. Operating in the Healthcare sector, WuXi Biologics (Cayman) Inc. has logged 7 insider filings. Market capitalisation: €136.2bn. The latest transaction was disclosed on 2 April 2026 (Other). Among the most active insiders: Gu Sherry Xuejun. All data is accessible without an account.